Kathy O'Briant

10.2k total citations · 1 hit paper
39 papers, 8.3k citations indexed

About

Kathy O'Briant is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kathy O'Briant has authored 39 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Kathy O'Briant's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Kathy O'Briant is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Kathy O'Briant collaborates with scholars based in United States, South Africa and United Kingdom. Kathy O'Briant's co-authors include Charles W. Drescher, Nicole Urban, Muneesh Tewari, Beatrice S. Knudsen, Rachael K. Parkin, Brian R. Fritz, Patrick S. Mitchell, Stacia K. Wyman, Evan M. Kroh and Robert Gentleman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Kathy O'Briant

39 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating microRNAs as stable blood-based markers for cancer detection

2008 6.5k citations Patrick S. Mitchell, Rachael K. Parkin et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Kathy O'Briant

Since Specialization

Citations

This map shows the geographic impact of Kathy O'Briant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy O'Briant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy O'Briant more than expected).

Fields of papers citing papers by Kathy O'Briant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy O'Briant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy O'Briant. The network helps show where Kathy O'Briant may publish in the future.

Co-authorship network of co-authors of Kathy O'Briant

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy O'Briant. A scholar is included among the top collaborators of Kathy O'Briant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy O'Briant. Kathy O'Briant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription 2011 ·Nucleic Acids Research ·Emily C. Knouf, Kavita S. Garg, Jason D. Arroyo, (unknown), Deepayan Sarkar, Rachael K. Parkin, Kaitlyn Wurz, Kathy O'Briant, Andrew K. Godwin, Nicole Urban, Walter L. Ruzzo, Robert Gentleman, Charles W. Drescher, Elizabeth M. Swisher, Muneesh Tewari	58
2	Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian Cancer 2011 ·JNCI Journal of the National Cancer Institute ·Nicole Urban, Jason D. Thorpe, Lindsay Bergan, (unknown), (unknown), Nathalie Scholler, Kathy O'Briant, Garnet L. Anderson, Daniel W. Cramer, Christine D. Berg, Martin McIntosh, Patricia Hartge, Charles W. Drescher	40
3	Integrative Proteomic Analysis of Serum and Peritoneal Fluids Helps Identify Proteins that Are Up-Regulated in Serum of Women with Ovarian Cancer 2010 ·PLoS ONE ·Lynn M. Amon, Wendy Law, Matthew Fitzgibbon, (unknown), Kathy O'Briant, Amelia C. Peterson, Charles W. Drescher, Daniel B. Martin, Martin McIntosh	30
4	Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries 2009 ·PLoS ONE ·Stacia K. Wyman, Rachael K. Parkin, Patrick S. Mitchell, Brian R. Fritz, Kathy O'Briant, Andrew K. Godwin, Nicole Urban, Charles W. Drescher, Beatrice S. Knudsen, Muneesh Tewari	193
5	Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case–Control Study 2009 ·JNCI Journal of the National Cancer Institute ·Garnet L. Anderson, Martin McIntosh, LieLing Wu, Matt J. Barnett, Gary E. Goodman, Jason D. Thorpe, Lindsay Bergan, Mark Thornquist, Nathalie Scholler, Nam Keun Kim, Kathy O'Briant, Charles W. Drescher, Nicole Urban	153
6	Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition 2009 ·Gynecologic Oncology ·Ausra Bendoraite, Emily C. Knouf, Kavita S. Garg, Rachael K. Parkin, Evan M. Kroh, Kathy O'Briant, Aviva P. Ventura, Andrew K. Godwin, Beth Y. Karlan, Charles W. Drescher, Nicole Urban, Beatrice S. Knudsen, Muneesh Tewari	168
7	Circulating microRNAs as stable blood-based markers for cancer detection breakdown → 2008 ·Proceedings of the National Academy of Sciences ·Patrick S. Mitchell, Rachael K. Parkin, Evan M. Kroh, Brian R. Fritz, Stacia K. Wyman, Era L. Pogosova‐Agadjanyan, Amelia C. Peterson, Jennifer Noteboom, Kathy O'Briant, April N. Allen, Daniel W. Lin, Nicole Urban, Charles W. Drescher, Beatrice S. Knudsen, Derek L. Stirewalt, Robert Gentleman, Robert L. Vessella, Peter S. Nelson, Daniel Martin, Muneesh Tewari	6512
8	Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular Domains 2008 ·PLoS ONE ·Vítor M. Faça, Aviva P. Ventura, (unknown), (unknown), Sharon J. Pitteri, (unknown), Reneé C. Ireton, Qing Zhang, Hong Wang, Kathy O'Briant, Charles W. Drescher, Michèl Schummer, Martin McIntosh, Beatrice S. Knudsen, Samir Hanash	105
9	Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q 2003 ·International Journal of Cancer ·Brad Stone, Michèl Schummer, Pamela J. Paley, Lucas Thompson, Julie Stewart, Molly M. Ford, (unknown), Nicole Urban, Kathy O'Briant, Brad H. Nelson	64
10	A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome 2001 ·Immunogenetics ·Craig L. Bennett, Mary E. Brunkow, Fred Ramsdell, Kathy O'Briant, Qili Zhu, Ramsay Fuleihan, Ann O. Shigeoka, Hans D. Ochs, Phillip F. Chance	190
11	Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. 2000 ·PubMed ·Fengfeng Xu, Steven A. Leadon, Yinhua Yu, C. Boyer, Kathy O'Briant, Kristy Ward, Amanda McWatters, Xiaoguang Zhao, Duk‐Soo Bae, K DeSombre, Michael R. Zalutsky, Robert C. Bast	11
12	SSA/RO52gene and expressed sequence tags in an 85 kb region of chromosome segment 11p15.5 2000 ·International Journal of Cancer ·Young Chul Kim, Youjia Cao, Diana M. Pitterle, Kathy O'Briant, Gerold Bepler	2
13	Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells. 1998 ·PubMed ·Gillian S. Dean, Lajos Pusztai, Fengfeng Xu, Kathy O'Briant, K DeSombre, Mark R. Conaway, C. Boyer, John Mendelsohn, Robert C. Bast	24
14	Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis. 1997 ·PubMed ·Fengfeng Xu, (unknown), C. Boyer, Kathy O'Briant, Regina S. Whitaker, Gordon B. Mills, Yanhong Yu, Robert C. Bast	61
15	Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B 1997 ·Genes Chromosomes and Cancer ·Kathy O'Briant, Gerold Bepler	28
16	Combinations of Multiple Serum Markers Are Superior to Individual Assays for Discriminating Malignant from Benign Pelvic Masses 1995 ·Gynecologic Oncology ·Robert Woolas, Mark R. Conaway, Fengji Xu, Ian Jacobs, Yinhua Yu, L. Daly, Ann Prys Davies, Kathy O'Briant, Andrew Berchuck, John T. Soper, Daniel L. Clarke‐Pearson, Gustavo Rodríguez, David Oram, Robert C. Bast	90
17	Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action. 1993 ·Journal of Clinical Investigation ·(unknown), Kathy O'Briant, Feng Xu, Thomas C. Hamilton, Robert F. Ozols, Robert C. Bast	16
18	A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast‐cancer cell lines 1992 ·International Journal of Cancer ·Jennie R. Crews, Lisa A. Maier, Yu Yin, Susan Hester, Kathy O'Briant, David S. Leslie, K DeSombre, Stephen L. George, Cinda M. Boyer, Yair Argon, Robert C. Bast	14
19	Ha-ras polymorphisms in epithelial ovarian cancer 1992 ·Gynecologic Oncology ·Kathy O'Briant, (unknown), Verda J. Hunter, (unknown), (unknown), L. Daly, Stephen L. George, A. Berchuck, John T. Soper, Wesley C. Fowler, Daniel L. Clarke‐Pearson, Robert C. Bast	4
20	Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres 1991 ·Cancer ·Kathy O'Briant, Elizabeth J. Shpall, (unknown), W. P. Peters, Robert C. Bast	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact